{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T05:08:39Z","timestamp":1693631319446},"reference-count":33,"publisher":"Wiley","issue":"9-10","license":[{"start":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T00:00:00Z","timestamp":1182988800000},"content-version":"vor","delay-in-days":3557,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1. The primary aim of the present study was to classify the receptors activated by tachykinins released by field stimulation of intramural nerve terminals of the guinea\u2010pig isolated main bronchus by using the novel non\u2010peptide NKi and NK<jats:sub>2<\/jats:sub> receptor\u2010selective antagonists SR140333 and SR 48968, respectively.<\/jats:p><jats:p>2. Log concentration\u2010response curves to substance P (SP), the NKi receptor\u2010selective agonist [Sar<jats:sup>9<\/jats:sup>, Met(O2)<jats:sup>11<\/jats:sup>]\u2010SP and the NK<jats:sub>2<\/jats:sub>receptor\u2010selective agonist [Nle<jats:sup>10<\/jats:sup>]\u2010neurokinin (NK) A(4\u201010) were constructed in the presence of indomethacin (2 \u03bcmol\/L) and phosphoramidon (5 (\u03bcmol\/L). Substance P was the least potent of these agonists.<\/jats:p><jats:p>3. In left and right main bronchi, SR 140333 (lOOnmol\/L) antagonized concentration\u2010related contractions evoked by SP yielding pK<jats:sub>B<\/jats:sub> values of 8.02 and 7.68, respectively. SR 140333 (10 nmol\/L) antagonized the effects of [Sar<jats:sup>9<\/jats:sup>, Met(O<jats:sub>2<\/jats:sub>)<jats:sup>11<\/jats:sup>]\u2010SP on the left bronchus with a pK<jats:sub>B<\/jats:sub> value of 8.04.<\/jats:p><jats:p>4. SR 48968 (100 nmol\/L) antagonized the effects of SP yielding pK<jats:sub>B<\/jats:sub> estimates of 7.88 (left bronchus) and 731 (right bronchus).<\/jats:p><jats:p>5. [Nle<jats:sup>10<\/jats:sup>]\u2010NKA(4\u201010) was more potent in the left than in the right main bronchus. SR 48968 (0.1\u201010 nmol\/L) antagonized the effects of [Nle<jats:sup>I0<\/jats:sup>]\u2010NKA(4\u201010) on the left bronchus with pK<jats:sub>B<\/jats:sub>estimates of 8.26\u201010.25.<\/jats:p><jats:p>6. In the presence of indomethacin (2 \u03bcmol\/L), phosphoramidon (5 \u03bcmol\/L) and atropine (1 (\u03bcmol\/L), electrical field stimulation (EFS; 30 V, 1ms, 15 s at <jats:bold>1, 3<\/jats:bold>, 10 and 30 Hz) produced prolonged contractions. SR 48968 (0.1 \u03bcmol\/L) markedly reduced responses to stimulation, whereas SR 140333 (0.3 \u03bcmol\/L) caused a small but significant rightward displacement of the log frequency\u2010response curve. In combination, these concentrations of SR 48968 and SR 140333 produced complete inhibition to field stimulation at 10 Hz.<\/jats:p><jats:p>7. These results indicate that: (i) both NK<jats:sub>1<\/jats:sub> and NK<jats:sub>2<\/jats:sub> receptor subtypes are present in the guinea\u2010pig main bronchi with the left bronchus being more sensitive to an NK<jats:sub>2<\/jats:sub> receptor agonist; and (ii) EFS of the main bronchus leads to frequency dependent contractions due to the release of tachykinin(s) that predominantly activate an NK2 receptor.<\/jats:p>","DOI":"10.1111\/j.1440-1681.1997.tb02111.x","type":"journal-article","created":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T06:35:54Z","timestamp":1183098954000},"page":"673-679","source":"Crossref","is-referenced-by-count":2,"title":["TACHYKININ RECEPTORS MEDIATING NON\u2010CHOLINERGIC CONTRACTION OF THE GUINEA\u2010PIG ISOLATED MAIN BRONCHUS IN RESPONSE TO FIELD STIMULATION"],"prefix":"10.1111","volume":"24","author":[{"given":"Melanie L.","family":"Heavey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnie AK","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn N.","family":"Pennefather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-6618(05)80045-3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90777-4"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90324-J"},{"key":"e_1_2_1_5_2","first-page":"201","article-title":"Non\u2010adrenergic non\u2010cholinergic (NANC) nerve\u2010mediated bronchoconstriction involves the activation of tachykinin NK2 receptors in the airways of the pithed guinea\u2010pig","volume":"3","author":"Lau WAK","year":"1993","journal-title":"Pharmacol. Commun."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1982.tb07170.x"},{"key":"e_1_2_1_7_2","first-page":"191","article-title":"In vivo and in vitro studies of the non\u2010adrenergic non\u2010cholinergic nervous system of the guinea\u2010pig airways","volume":"280","author":"Karlsson JA.","year":"1986","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb14803.x"},{"key":"e_1_2_1_9_2","first-page":"147","article-title":"Radioiodinated substance P, neurokinin A and eledoisin bind predominantly to NKi receptors in guinea\u2010pig lung","volume":"41","author":"Geraghty DP","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13867.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90352-P"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1996.tb02582.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90517-T"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90027-F"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1981.tb00884.x"},{"key":"e_1_2_1_16_2","first-page":"292","article-title":"Influence of epithelium on guinea\u2010pig airway responses to tachykinins: Role of endopeptidase and cyclo\u2010oxygenase","volume":"248","author":"Frossard N.","year":"1989","journal-title":"J. Pharmacol. Exp. Then"},{"key":"e_1_2_1_17_2","first-page":"824","article-title":"Pharmacologic studies on the differential influence of inhibitors of neutral endopeptidase on nonadren\u2010ergic, noncholinergic contractile responses of the guinea\u2010pig isolated hilar bronchus to transmural electrical stimulation and exogenously applied tachykinins","volume":"254","author":"Warner EA","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90797-8"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1990.69.4.1336"},{"key":"e_1_2_1_20_2","volume-title":"Documenta Geigy Scientific Tables","author":"Diem K.","year":"1970"},{"key":"e_1_2_1_21_2","volume-title":"Handbook of Experimental Pharmacology, vol. 33, Catecholamines","author":"Furchgott RF.","year":"1972"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1959.tb00928.x"},{"key":"e_1_2_1_23_2","first-page":"957","article-title":"Nonadrenergic, noncholinergic contractile responses of the guinea\u2010pig hilar bronchus involve the preferential activation of tachykinin neurokinin\u20102 receptors","volume":"262","author":"Renzetti LM","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(92)90286-S"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(93)90058-G"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90632-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(90)90320-8"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00921-X"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1200"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb15851.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1991.tb12390.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)80041-5"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1183\/09031936.93.06050735","article-title":"Tachykinin receptors and airway pathophysiology","volume":"6","author":"Maggi CA.","year":"1993","journal-title":"Eur. Respir. J."},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.2.363"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.1997.tb02111.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.1997.tb02111.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:44:58Z","timestamp":1693590298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.1997.tb02111.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":33,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1440-1681.1997.tb02111.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.1997.tb02111.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}